Effects of polygeline and hydroxyethyl starch solutions on liver functions assessed with LIMON in hypovolemic patients

Journal of Critical Care

Volumn 25, Issue 2, 2010, Pages 361.e1-361.e5

  Inal, Mehmet Turan ^a   Memiş, Dilek ^a   Karamanlioglu, Beyhan ^a   Sut, Necdet ^a  

^a TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Indocyanine green; Plasma disappearance rate, Colloid solutions

Indexed keywords

HETASTARCH; INDOCYANINE GREEN; POLYGELINE;

ADULT; ARTICLE; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITOMETRY; DIASTOLIC BLOOD PRESSURE; FEMALE; FLUID RESUSCITATION; HEART OUTPUT; HEMODYNAMICS; HUMAN; HYPOVOLEMIA; LIVER FUNCTION; MALE; OXYGEN THERAPY; PATIENT MONITORING; POSITIVE END EXPIRATORY PRESSURE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; THERMODILUTION;

EID: 77953291665     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2009.06.013     Document Type: Article

References (23)

1. Spapen H. Liver perfusion in sepsis, septic shock, and multiorgan failure. Anat Rec (Hoboken). 2008, 291:714-720.
2. Sakka S.G., Bredle D.L., Reinhart K., Meier-Hellmann A. Comparison between intrathoracic blood volume and cardiac filling pressures in the early phase of hemodynamic instability of patients with sepsis or septic shock. J Crit Care 1999, 14:78-83.
3. Bagshaw S.M., Bellomo R. The influence of volume management on outcome. Curr Opin Crit Care 2007, 13:541-548.
4. Molnar Z., Mikor A., Leiner T., Szakmany T. Fluid resuscitation with colloids of different molecular weight in septic shock. Intensive Care Med 2004, 30:1356-1360.
5. Wiedermann C.J. Systematic review of randomized trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med 2008, 8:1.
6. Faybik P., Krenn C.G., Baker A., Lahner D., Berlakovich G., Steltzer H., et al. Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study. Liver Transpl 2004, 10:1060-1064.
7. Leevy C.M., Smith F., Longueville J., Paumgartner G., Howard M.M. Indocyanine green clearance as a test for hepatic function. Evaluation by dichromatic ear densitometry. JAMA 1967, 200:236-240.
8. Sakka S.G., Reinhart K., Meier-Hellmann A. Comparison of invasive and noninvasive measurements of indocyanine green plasma disappearance rate in critically ill patients with mechanical ventilation and stable hemodynamics. Intensive Care Med 2000, 26:1553-1557.
9. Hsieh C.B., Chen C.J., Chen T.W., et al. Accuracy of indocyanine green pulse spectrophotometry clearance test for liver function prediction in transplanted patients. World J Gastroenterol 2004, 10:2394-2396.
10. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:204-212.
11. Sakr Y., Dubois M.J., De Backer D., Creteur J., Vincent J.L. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004, 32:1825-1831.
12. Cottis R., Magee N., Higgins D.J. Haemodynamic monitoring with pulse-induced contour cardiac output (PiCCO) in critical care. Intensive Crit Care Nurs 2003, 19:301-307.
13. Lichtwarck-Aschoff M., Zeravik J., Pfeiffer U.J. Intrathoracic blood volume accurately reflects circulatory volume status in critically ill patients with mechanical ventilation. Intensive Care Med 1992, 18:142-147.
14. Hofmann D., Thuemer O., Schelenz C., van Hout N., Sakka S.G. Increasing cardiac output by fluid loading: effects on indocyanine green plasma disappearance rate and splanchnic microcirculation. Acta Anaesthesiol Scand 2005, 49:1280-1286.
15. Kholoussy A.M., Pollack D., Matsumoto T. Prognostic significance of indocyanine green clearance in critically ill surgical patients. Crit Care Med 1984, 12:115-116.
16. Sakka S.G., Reinhart K., Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 2002, 122:1715-1720.
17. Boldt J., Heesen M., Müller M., Pabsdorf M., Hempelmann G. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 1996, 83:254-261.
18. Asfar P., Kerkeni N., Labadie F., Gouëllo J.P., Brenet O., Alquier P. Assessment of hemodynamic and gastric mucosal acidosis with modified fluid versus 6% hydroxyethyl starch: a prospective, randomized study. Intensive Care Med 2000, 26:1282-1287.
19. Hoffmann J.N., Vollmar B., Laschke M.W., Inthorn D., Schildberg F.W., Menger M.D. Hydroxyethyl starch (130 kD), but not crystalloid volume support, improves microcirculation during normotensive endotoxemia. Anesthesiology 2002, 97:460-470.
20. Dienes H.P., Gerharz C.D., Wagner R., Weber M., John H.D. Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension. J Hepatol 1986, 3:223-227.
21. Sirtl C., Laubenthal H., Zumtobel V., Kraft D., Jurecka W. Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth 1999, 82:510-515.
22. Laxenaire M.C., Charpentier C., Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim 1994, 13:301-310.
23. Christidis C., Mal F., Ramos J., Senejoux A., Callard P., Navarro R., et al. Worsening of hepatic dysfunction as a consequence of repeated hydroxyethyl starch infusions. J Hepatol 2001, 35:726-732.